2 weeks Ago By Defense World Staff
Charles Schwab Investment Management Inc. trimmed its holdings in shares of RadNet, Inc. (NASDAQ:RDNT – Free Report) by 2.
1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 624,190 shares of the medical research company’s stock after selling 13,121 shares during the period. Charles Schwab Investment Management Inc.
owned 0.84% of RadNet worth $43,593,000 as of its most recent SEC filing. A number of other hedge funds and other institutional investors have also recently bought and sold shares of RDNT.
Covestor Ltd increased its stake in shares of RadNet by 10,875.0% in the 3rd quarter. Covestor Ltd now owns 439 shares of the medical research company’s stock valued at $30,000 after buying an additional 435 shares during the period.
USA Financial Formulas acquired a new stake in shares of RadNet in the 4th quarter valued at $30,000. Fifth Third Bancorp increased its stake in shares of RadNet by 84.3% in the 4th quarter.
Fifth Third Bancorp now owns 667 shares of the medical research company’s stock valued at $47,000 after buying an additional 305 shares during the period. Peterson Financial Group Inc. acquired a new stake in shares of RadNet in the 3rd quarter valued at $90,000.
Finally, Smartleaf Asset Management LLC increased its stake in shares of RadNet by 377.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,345 shares of the medical research company’s stock valued at $96,000 after buying an additional 1,063 shares during the period.
77.90% of the stock is owned by institutional investors and hedge funds. Insider Buying and SellingIn related news, CEO Cornelis Wesdorp sold 1,000 shares of the business’s stock in a transaction dated Friday, March 7th.
The stock was sold at an average price of $50.52, for a total value of $50,520.00.
Following the completion of the sale, the chief executive officer now directly owns 55,995 shares of the company’s stock, valued at $2,828,867.40. The trade was a 1.
75 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director David L.
Swartz sold 25,000 shares of the business’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $50.84, for a total value of $1,271,000.
00. Following the completion of the sale, the director now directly owns 174,067 shares of the company’s stock, valued at $8,849,566.28.
The trade was a 12.56 % decrease in their ownership of the stock. The disclosure for this sale can be found here.
Insiders sold a total of 28,000 shares of company stock valued at $1,426,680 in the last three months. Insiders own 5.12% of the company’s stock.
Wall Street Analysts Forecast GrowthA number of equities research analysts recently commented on the company. Jefferies Financial Group decreased their price objective on RadNet from $100.00 to $80.
00 and set a “buy” rating for the company in a research note on Wednesday, January 15th. Truist Financial reaffirmed a “buy” rating and set a $88.00 price objective (down from $94.
00) on shares of RadNet in a research note on Wednesday, January 22nd. Raymond James raised RadNet from an “outperform” rating to a “strong-buy” rating and decreased their price objective for the stock from $85.00 to $65.
00 in a research note on Wednesday, March 5th. Finally, Barclays decreased their price objective on RadNet from $85.00 to $74.
00 and set an “overweight” rating for the company in a research note on Wednesday, January 22nd. One analyst has rated the stock with a sell rating, three have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.
com, the stock presently has a consensus rating of “Buy” and a consensus price target of $76.75.View Our Latest Analysis on RDNTRadNet Trading Up 1.
4 %Shares of RDNT stock opened at $46.54 on Friday. The stock’s fifty day moving average price is $61.
00 and its two-hundred day moving average price is $68.01. The company has a market cap of $3.
45 billion, a PE ratio of -664.76 and a beta of 1.85.
RadNet, Inc. has a fifty-two week low of $42.45 and a fifty-two week high of $93.
65. The company has a debt-to-equity ratio of 0.89, a quick ratio of 2.
16 and a current ratio of 2.16. RadNet (NASDAQ:RDNT – Get Free Report) last issued its earnings results on Thursday, February 27th.
The medical research company reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.21 by $0.
01. RadNet had a positive return on equity of 4.29% and a negative net margin of 0.
25%. The firm had revenue of $477.10 million for the quarter, compared to the consensus estimate of $459.
42 million. Equities analysts predict that RadNet, Inc. will post 0.
56 EPS for the current fiscal year. RadNet Profile (Free Report)RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence.
Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.Featured ArticlesFive stocks we like better than RadNetAre These Liquid Natural Gas Stocks Ready For An Upside Bounce?Rubrik Stock’s V-Bottom Reversal Signals a Major Rally AheadThe Basics of Support and ResistanceHow Super Micro Computer Stock Is Defying the Market Sell-OffHow to Calculate Return on Investment (ROI)AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?Want to see what other hedge funds are holding RDNT? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for RadNet, Inc. (NASDAQ:RDNT – Free Report)..
